SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Lane3 who wrote (13364)2/9/2010 12:47:51 PM
From: TimF  Read Replies (1) | Respond to of 42652
 
I don't know how you can compete on drugs. Some of them are basically equivalents

With those at least (and of course with off patent drugs) you can get competition. One of the reasons the off derided, or implied as almost useless, "me too drugs", are actually useful. For the not quite as close drugs that treat the same condition and may also be called "me too" the fact that they have slightly different sets of effects is useful to the effort to find something that works right for the particular patient.



To: Lane3 who wrote (13364)2/9/2010 1:42:35 PM
From: Road Walker  Read Replies (1) | Respond to of 42652
 
The mind boggles at the thought.

Not mine.

I find it ironic to see competition advocated as a way to acquire drugs for an anti-competitive system. <g>

It is ironic. But there it is. Otherwise you just let companies charge whatever they want. That's not currently working as a free market model.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News